{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:07:15Z","timestamp":1792037235306,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","award":["2023A1515110913"],"award-info":[{"award-number":["2023A1515110913"]}],"id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001855"],"award-info":[{"award-number":["82001855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110174","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:04:05Z","timestamp":1782774245000},"page":"110174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preclinical evaluation of novel FGFR2-targeting peptide probes for PET imaging and intraoperative navigation in gastric Cancer"],"prefix":"10.1016","volume":"180","author":[{"given":"Xiaoqiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110174_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110174_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110174_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110174_bb0020","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/atm-20-7953","article-title":"Differential prognostic implications of gastric adenocarcinoma based on Lauren\u2019s Classification: a surveillance, epidemiology, and end results (SEER)-based cohort study","volume":"9","author":"Tang","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110174_bb0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bioorg.2026.110174_bb0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2022.06.025","article-title":"Microsatellite instability and sex differences in Resectable gastric Cancer - a pooled analysis of three European cohorts","volume":"173","author":"Quaas","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"7","key":"10.1016\/j.bioorg.2026.110174_bb0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jjco\/hyab049","article-title":"Benefit of surgical resection of distant metastasis in soft tissue sarcoma: a systematic review","volume":"51","author":"Hayashi","year":"2021","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"9742","key":"10.1016\/j.bioorg.2026.110174_bb0040","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.bioorg.2026.110174_bb0045","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1200\/JCO.23.01601","article-title":"First-line nivolumab plus chemotherapy for advanced gastric, gastroesophageal junction, and Esophageal adenocarcinoma: 3-year follow-up of the phase III CheckMate 649 trial","volume":"42","author":"Janjigian","year":"2024","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"10418","key":"10.1016\/j.bioorg.2026.110174_bb0050","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","article-title":"Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial","volume":"402","author":"Janjigian","year":"2023","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.bioorg.2026.110174_bb0055","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2023.19918","article-title":"Sintilimab plus chemotherapy for unresectable gastric or gastroesophageal junction cancer: the ORIENT-16 randomized clinical trial","volume":"330","author":"Xu","year":"2023","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110174_bb0060","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat. Med."},{"issue":"10389","key":"10.1016\/j.bioorg.2026.110174_bb0065","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110174_bb0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10120-024-01466-w","article-title":"Bemarituzumab as first-line treatment for locally advanced or metastatic gastric\/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial","volume":"27","author":"Wainberg","year":"2024","journal-title":"Gastric Cancer"},{"issue":"22","key":"10.1016\/j.bioorg.2026.110174_bb0075","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1242\/dev.152587","article-title":"Fibroblast growth factors: key players in regeneration and tissue repair","volume":"144","author":"Maddaluno","year":"2017","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110174_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to Cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110174_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1158\/1078-0432.CCR-14-3212","article-title":"The FGFR landscape in Cancer: analysis of 4,853 Tumors by next-generation sequencing","volume":"22","author":"Helsten","year":"2016","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110174_bb0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41416-020-01157-0","article-title":"Fibroblast growth factor receptors in Cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance","volume":"124","author":"Krook","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110174_bb0095","first-page":"1046","article-title":"Bemarituzumab plus mFOLFOX6 as first-line treatment in east Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric\/gastroesophageal junction Cancer: subgroup of FIGHT final analysis","volume":"27","author":"Kang","year":"2024","journal-title":"Gastric Cancer Off. J. Int. Gastric Cancer Assoc. Jpn. Gastric Cancer Assoc."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110174_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR Signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110174_bb0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12029-025-01172-5","article-title":"Nivolumab combined with chemotherapy in FGFR2 and PD-L1 Co-expressing metastatic gastric Cancer: a prospective phase 2 NIVOFGFR2 study","volume":"56","author":"Tsimafeyeu","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"issue":"28","key":"10.1016\/j.bioorg.2026.110174_bb0110","doi-asserted-by":"crossref","first-page":"14181","DOI":"10.1073\/pnas.1817442116","article-title":"Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix","volume":"116","author":"Jailkhani","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110174_bb0115","first-page":"1326","article-title":"Efficacy of peptide receptor radionuclide therapy for Esthesioneuroblastoma","volume":"61","author":"Hasan","year":"2020","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110174_bb0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/anie.201507596","article-title":"Enzyme-mediated modification of single-domain antibodies for imaging modalities with different characteristics","volume":"55","author":"Rashidian","year":"2016","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bioorg.2026.110174_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.eng.2024.01.006","article-title":"STAT3-dependent effects of polymeric immunoglobulin receptor in regulating Interleukin-17 Signaling and preventing autoimmune hepatitis","volume":"36","author":"Li","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.bioorg.2026.110174_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eng.2023.09.012","article-title":"Antibodies targeting a conserved surface polysaccharide are protective against a wide range of microbial pathogens producing \u03b2-1\u20136-linked poly-N-acetylglucosamine (PNAG)","volume":"38","author":"Lu","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.bioorg.2026.110174_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.eng.2024.04.011","article-title":"Initial experience of NIR-II fluorescence imaging-guided surgery in foot and ankle surgery","volume":"40","author":"Fan","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.bioorg.2026.110174_bb0140","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eng.2023.11.012","article-title":"Targeted therapy of central nervous system acute lymphoblastic Leukemia with an integrin \u03916-targeted self-assembling proapoptotic Nanopeptide","volume":"35","author":"Ye","year":"2024","journal-title":"Engineering"},{"key":"10.1016\/j.bioorg.2026.110174_bb0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.eng.2025.06.035","article-title":"Targeting IGF2BP2\u2013CEMIP boosts antiangiogenic therapy in colorectal cancer in mice","volume":"52","author":"Chen","year":"2025","journal-title":"Engineering"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110174_bb0150","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1021\/acs.bioconjchem.3c00442","article-title":"Formulation and preclinical testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-targeting tumor radiotracer","volume":"34","author":"Yang","year":"2023","journal-title":"Bioconjug. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110174_bb0155","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1021\/acsomega.1c05856","article-title":"Development of a radiotracer for PET imaging of the SNAP tag","volume":"7","author":"Li","year":"2022","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110174_bb0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s43657-024-00194-6","article-title":"Integrin \u03916 targeted tumor Theranostics","volume":"5","author":"Li","year":"2025","journal-title":"Phenomics"},{"issue":"50","key":"10.1016\/j.bioorg.2026.110174_bb0165","doi-asserted-by":"crossref","first-page":"87095","DOI":"10.18632\/oncotarget.19764","article-title":"Identification and validation of FGFR2 peptide for detection of early Barrett\u2019s neoplasia","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826007108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:33:27Z","timestamp":1787675607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826007108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"alternative-id":["S0045206826007108"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110174","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of novel FGFR2-targeting peptide probes for PET imaging and intraoperative navigation in gastric Cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110174"}}